000 01318 a2200397 4500
005 20250514045635.0
264 0 _c20030220
008 200302s 0 0 eng d
022 _a1424-7860
024 7 _a10.4414/smw.2002.10061
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHirschel, Bernard
245 0 0 _aNew drugs, old drugs - dear drugs, cheap drugs.
_h[electronic resource]
260 _bSwiss medical weekly
_cJun 2002
300 _a301-2 p.
_bdigital
500 _aPublication Type: Editorial; Comment
650 0 4 _aAmphotericin B
_xadverse effects
650 0 4 _aAnti-Bacterial Agents
_xeconomics
650 0 4 _aAntifungal Agents
_xadverse effects
650 0 4 _aBone Marrow Transplantation
650 0 4 _aCaspofungin
650 0 4 _aCyclosporine
_xadverse effects
650 0 4 _aEchinocandins
650 0 4 _aHumans
650 0 4 _aLipopeptides
650 0 4 _aMycoses
_xdrug therapy
650 0 4 _aPeptides
650 0 4 _aPeptides, Cyclic
650 0 4 _aPyrimidines
_xeconomics
650 0 4 _aRenal Insufficiency
_xchemically induced
650 0 4 _aTriazoles
_xeconomics
650 0 4 _aVoriconazole
700 1 _aGarbino, Jorge
773 0 _tSwiss medical weekly
_gvol. 132
_gno. 23-24
_gp. 301-2
856 4 0 _uhttps://doi.org/10.4414/smw.2002.10061
_zAvailable from publisher's website
999 _c12174164
_d12174164